Literature DB >> 6932914

In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer.

S Rockwell.   

Abstract

In vivo-in vitro tumour cell lines are widely used to study the biology of cancer and to examine the factors influencing the response of tumours to therapeutic agents and regimens. The existing in vivo-in vitro tumours form a uniform and artificial population of experimental neoplasms, with biological characteristics which limit the acceptability of any of these tumours or panel of these tumours as an accurate model for human cancer. All are rapidly growing, transplanted tumours in highly inbred rodents. All have growth rates, cell proliferation patterns and tumour-host interactions different from those of primary tumours in animals or man. Most are immunogenic. Most are anaplastic sarcomas: few are carcinomas; none are well differentiated. The biological differences between in vivo-in vitro tumours and human neoplasms must be considered when the experimental systems are used as models for human cancer.

Entities:  

Mesh:

Year:  1980        PMID: 6932914      PMCID: PMC2149198     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  12 in total

1.  An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions.

Authors:  J E Thomson; A M Rauth
Journal:  Radiat Res       Date:  1974-05       Impact factor: 2.841

2.  Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.

Authors:  R L Ullrich; L M Adams
Journal:  Radiat Res       Date:  1978-02       Impact factor: 2.841

3.  Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.

Authors:  N J McNally; J Denekamp; P Sheldon; I R Flockhart; F A Stewart
Journal:  Radiat Res       Date:  1978-03       Impact factor: 2.841

4.  Growth and cell population kinetics of single and multiple KHT sarcomas.

Authors:  S Rockwell; R F Kallman
Journal:  Cell Tissue Kinet       Date:  1972-11

5.  Radiation response and characteristics of a cell line derived from a mouse mammary adenocarcinoma.

Authors:  K R Meyer; L E Hopwood; E L Gillette
Journal:  Radiat Res       Date:  1978-02       Impact factor: 2.841

Review 6.  The choice of animal tumors for experimental studies of cancer therapy.

Authors:  H B Hewitt
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

7.  Properties of the H-4-II-E tumor cell system. I. Growth and cell proliferation kinetics of an experimental hepatoma.

Authors:  M J Evans; C J Kovacs
Journal:  Cell Tissue Kinet       Date:  1977-05

8.  Brain-tumor therapy. Quantitative analysis using a model system.

Authors:  M K Rosenblum; K D Knebel; D A Vasquez; C B Wilson
Journal:  J Neurosurg       Date:  1977-02       Impact factor: 5.115

Review 9.  In vivo-in vitro tumor systems: new models for studing the response of tumours to therapy.

Authors:  S Rockwell
Journal:  Lab Anim Sci       Date:  1977-10

10.  A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse.

Authors:  V D Courtenay
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

View more
  17 in total

1.  Method for obtaining primary ovarian cancer cells from solid specimens.

Authors:  Lee J Pribyl; Kathleen A Coughlin; Thanasak Sueblinvong; Kristin Shields; Yoshie Iizuka; Levi S Downs; Rahel G Ghebre; Martina Bazzaro
Journal:  J Vis Exp       Date:  2014-02-04       Impact factor: 1.355

Review 2.  Real-time intravital imaging of cancer models.

Authors:  A Zomer; E Beerling; E J Vlug; J van Rheenen
Journal:  Clin Transl Oncol       Date:  2011-12       Impact factor: 3.405

3.  A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs.

Authors:  Zuzana Tatarova; Dylan C Blumberg; James E Korkola; Laura M Heiser; John L Muschler; Pepper J Schedin; Sebastian W Ahn; Gordon B Mills; Lisa M Coussens; Oliver Jonas; Joe W Gray
Journal:  Nat Biotechnol       Date:  2022-07-04       Impact factor: 68.164

4.  Correlative effect between in vivo hollow fiber assay and xenografts assay in drug screening.

Authors:  Keyong Ho Lee; Ki Hyeong Rhee
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

Review 5.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 6.  Experimental systems for analysis of the malignant phenotype.

Authors:  G Poste
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

7.  Responses of a murine B16 melanoma to pharmacotherapy studied and compared with different assay systems.

Authors:  Y Kuwashima; O Matsubara; T Kasuga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

8.  Biological properties of a spontaneous murine tumour (STS) suitable for in vitro-in vivo studies.

Authors:  T E Wheldon; H C Walker; J Burgin; A S Michalowski; C Rowlatt
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

9.  Comparison of tumour age response to radiation for cells derived from tissue culture or solid tumours.

Authors:  P C Keng; D W Siemann; K T Wheeler
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

10.  New model for gastroenteropancreatic large-cell neuroendocrine carcinoma: establishment of two clinically relevant cell lines.

Authors:  Andreas Krieg; Sabrina Mersch; Inga Boeck; Levent Dizdar; Eberhard Weihe; Zena Hilal; Markus Krausch; Birte Möhlendick; Stefan A Topp; Roland P Piekorz; Wolfgang Huckenbeck; Nikolas H Stoecklein; Martin Anlauf; Wolfram T Knoefel
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.